Literature DB >> 11670402

Ruthenium Nitrosyl Complexes with N-Heterocyclic Ligands.

Simone da S. S. Borges1, Celso U. Davanzo, Eduardo E. Castellano, Julio Z-Schpector, Sebastião C. Silva, Douglas W. Franco.   

Abstract

A new route was developed for preparing a series of trans nitrosyl complexes of general formula trans-[Ru(NH(3))(4)L(NO)](BF(4))(3), where L = imidazole, L-histidine, pyridine, or nicotinamide. The complexes have been characterized by elemental analysis, molar conductance measurements, UV-visible, infrared, proton nuclear magnetic, and electron paramagnetic resonance spectroscopies, and electrochemical techniques. The compounds possess relatively high nu(NO) stretching frequencies indicating that a high degree of positive charge resides on the coordinated nitrosyl group. The nitrosyl complexes react with OH(-) according to the equation trans-[Ru(NH(3))(4)L(NO)](3+) + 2OH(-) right arrow over left arrow trans-[Ru(NH(3))(4)L(NO(2))](+) + H(2)O, with a K(eq) (at 25.0 degrees C in 1.0 mol/L NaCl) of 2.2 x 10(5), 5.9 x 10(7), 9.7 x 10(10), and 4.6 x 10(13) L(2) mol(-)(2) for the py, nic, imN, and L-hist complexes, respectively. Only one redox process attributed to the reaction [Ru(II)(NH(3))(4)L(NO(+))](3+) + e(-) right arrow over left arrow trans-[Ru(II)(NH(3))(4)L(NO(0))](2+) was observed in the range -0.45 to 1.20 V for all the nitrosyl complexes. Linear correlations are observed in plots of nu(NO) versus E(1/2) and of E(1/2) versus summation operatorE(L) showing that the oxidizing strength of the coordinated NO increases with increase in L pi-acidity. The crystal structure analysis of trans-[Ru(NH(3))(4)nicNO](2)(SiF(6))(3) shows that the mean Ru-N-O angle is very close to 180 degrees (177 +/- 1 degrees ) and the mean N-O distance is 1.17 +/- 0.02 Å, thus confirming the presence of the Ru(II)-NO(+) moiety in the nitrosyl complexes studied.

Entities:  

Year:  1998        PMID: 11670402     DOI: 10.1021/ic951563s

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  7 in total

1.  Photoactive Ruthenium Nitrosyls: Effects of Light and Potential Application as NO Donors.

Authors:  Michael J Rose; Pradip K Mascharak
Journal:  Coord Chem Rev       Date:  2008-10-01       Impact factor: 22.315

2.  Targeting the mitochondrial VDAC in hepatocellular carcinoma using a polyclonal antibody-conjugated to a nitrosyl ruthenium complex.

Authors:  Loyanne C B Ramos; Fernando P Rodrigues; Juliana C Biazzotto; Sergio de Paula Machado; Leonardo D Slep; Michael R Hamblin; Roberto S da Silva
Journal:  J Biol Inorg Chem       Date:  2018-07-03       Impact factor: 3.358

3.  Experimental chemotherapy in paracoccidioidomycosis using ruthenium NO donor.

Authors:  Wander Rogério Pavanelli; Jean Jerley Nogueira da Silva; Carolina Panis; Thiago Mattar Cunha; Ivete Conchon Costa; Maria Claudia Noronha Dutra de Menezes; Francisco José de Abreu Oliveira; Luiz Gonzaga de França Lopes; Rubens Cecchini; Fernando de Queiroz Cunha; Maria Angélica Ehara Watanabe; Eiko Nakagawa Itano
Journal:  Mycopathologia       Date:  2011-03-25       Impact factor: 2.574

4.  Ruthenium nitrosyls derived from tetradentate ligands containing carboxamido-N and phenolato-o donors: syntheses, structures, photolability, and time dependent density functional theory studies.

Authors:  Nicole L Fry; Michael J Rose; David L Rogow; Crystal Nyitray; Manpreet Kaur; Pradip K Mascharak
Journal:  Inorg Chem       Date:  2010-02-15       Impact factor: 5.165

5.  Experimental chemotherapy against Trypanosoma cruzi infection using ruthenium nitric oxide donors.

Authors:  Jean Jerley N Silva; Wander R Pavanelli; José Clayston M Pereira; João S Silva; Douglas W Franco
Journal:  Antimicrob Agents Chemother       Date:  2009-07-06       Impact factor: 5.191

6.  Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity.

Authors:  Jean Jerley Nogueira Silva; Paulo Marcos Matta Guedes; Aderson Zottis; Tatiane Luciano Balliano; Francisco Ordelei Nascimento Silva; Luiz Gonzaga França Lopes; Javier Ellena; Glaucius Oliva; Adriano Defini Andricopulo; Douglas Wagner Franco; João Santana Silva
Journal:  Br J Pharmacol       Date:  2010-01-26       Impact factor: 8.739

7.  In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors.

Authors:  J J N Silva; A L Osakabe; W R Pavanelli; J S Silva; D W Franco
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.